Sanofi-Aventis U.S. LLC 2023-05-24 Health serious FDA
Health · FDA · Recall #FDA-D-0575-2023
Admelog, insulin lispro injection, 100 units/mL (U-100), 3mL multi-dose vial, Rx Only,… Recall
Issued May 24, 2023 · Sanofi-Aventis U.S. LLC
In May 2023, Sanofi-Aventis U.S. LLC recalled the Admelog, insulin lispro injection, 100 units/mL (U-100), 3mL multi-dose vial, Rx Only,…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Lack of Assurance of Sterility: Malformed crimped collar seal
What you should do
- 1 Stop using Admelog, insulin lispro injection, 100 units/mL (U-100), 3mL multi-dose vial, Rx Only,… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Sanofi-Aventis U.S. LLC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Sanofi-Aventis U.S. LLC
- Category
- Health
- Recall date
- May 24, 2023
- Units affected
- Not reported
- Sold at
- Nationwide in the USA
- Recall number
- FDA-D-0575-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- Sanofi-Aventis U.S. LLC has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.